ARR visited the individuals and contributed to writing the manuscript. SN designed the study, visited the individuals, and contributed to writing the manuscript. SD did statistical analyses and contributed to the writing of the manuscript. RL collected clinical data. EB and CMu visited the individuals and contributed to the writing of the manuscript. GC, IM, CMa, and CC visited the individuals and contributed to the reviewing of the manuscript. AC coordinated clinical activities and contributed to the reviewing of the manuscript. ARR and SN directly accessed and verified the underlying data reported in the manuscript. All authors had full access to all the data in the study and accept responsibility to submit for publication. All authors have seen and approved of the final text. AC has received personal fees for advisory boards, speaker panels, and educational materials from Gilead Sciences, ViiV Healthcare, Janssen-Cilag, Merck Sharp & Dohme, and Theratechnlogies. SN has received personal fees for advisory boards, speaker panels, and educational materials from Gilead Sciences, ViiV Healthcare, Janssen-Cilag, and Merck Sharp & Dohme. All other authors declare no competing interests. All data collected in the study are available upon reasonable request, after approval of proposal, to the corresponding author, including deidentified participant-level data. There was no funding for this study.